Literature DB >> 16765558

Management of endometrial cancer.

H Kitchener1.   

Abstract

AIM: To review broadly the diagnosis and treatment of endometrial cancer, concentrating on the evidence base.
METHODS: The peer reviewed literature has been cited selectively to support the principal themes of the review.
RESULTS: A rising incidence of endometrial cancer will continue to present challenges to improve survival particularly for high-risk and advanced disease. Lymphadenectomy and adjuvant radiotherapy are and will be used more rationally as evidence for their effectiveness accumulates.
CONCLUSIONS: The area of greatest need in endometrial cancer is now to improve outcomes for women with advanced/recurrent disease.

Entities:  

Mesh:

Year:  2006        PMID: 16765558     DOI: 10.1016/j.ejso.2006.03.046

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  8 in total

Review 1.  Chemoresistance and targeting of growth factors/cytokines signalling pathways: towards the development of effective therapeutic strategy for endometrial cancer.

Authors:  Fengjun Guo; Haina Zhang; Zanhui Jia; Manhua Cui; Jingyan Tian
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

2.  Expression and in vitro functions of the ghrelin axis in endometrial cancer.

Authors:  Jenny N T Fung; Inge Seim; Dengfeng Wang; Andreas Obermair; Lisa K Chopin; Chen Chen
Journal:  Horm Cancer       Date:  2010-10       Impact factor: 3.869

3.  Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.

Authors:  Vijay Pandey; Jo K Perry; Kumarasamypet M Mohankumar; Xiang-Jun Kong; Shu-Min Liu; Zheng-Sheng Wu; Murray D Mitchell; Tao Zhu; Peter E Lobie
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

4.  Controversies in the management of endometrial carcinoma.

Authors:  Ying Zhang; Jian Wang
Journal:  Obstet Gynecol Int       Date:  2010-06-22

5.  Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.

Authors:  Andrea Mariani; Sean C Dowdy; William A Cliby; Bobbie S Gostout; Monica B Jones; Timothy O Wilson; Karl C Podratz
Journal:  Gynecol Oncol       Date:  2008-03-04       Impact factor: 5.482

6.  Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners.

Authors:  Rive Sarfstein; Yael Friedman; Zohar Attias-Geva; Ami Fishman; Ilan Bruchim; Haim Werner
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

Review 7.  Diagnostic accuracy of preoperative tests for lymph node status in endometrial cancer: a systematic review.

Authors:  H M P Pelikan; J W Trum; F C H Bakers; R G H Beets-Tan; L J M Smits; R F P M Kruitwagen
Journal:  Cancer Imaging       Date:  2013-07-22       Impact factor: 3.909

8.  Regulation of insulin-like growth factor signaling by metformin in endometrial cancer cells.

Authors:  Ya Xie; Jing-Lu Wang; Mei Ji; Zhong-Fu Yuan; Zheng Peng; Yi Zhang; Jian-Guo Wen; Hui-Rong Shi
Journal:  Oncol Lett       Date:  2014-08-20       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.